ReviewPublished 25 September 2026CLDN18 and FGFR2 splicing variants are emerging tumor-associated antigens for cancer therapyMasuko Katoh · Masaru KatohFrontiers in Molecular Medicinedoi 10.3389/fmmed.2026.1927389
ReviewPublished 15 September 2026The future directions of CAR-T Cell therapy: unlocking the potential of immunotherapy in cancer treatmentAngel Alberto Justiz-Vaillant · Sachin Soodeen · Rodolfo Arozarena-Fundora · Patrick Eberechi Akpaka · Chandrashekhar UnakalFrontiers in Molecular Medicinedoi 10.3389/fmmed.2026.1931159
